PROBLEM & SOLUTION
Across Africa, investment in pathogen genomics has expanded dramatically. Africa CDC-affiliated researchers report that the number of national public-health institutions and reference laboratories with functional sequencing capacity grew from 7 in 2018–2019 to 46 by April 2025.
But producing a FASTQ file is not the same as producing trustworthy genomic evidence.
Before raw sequencing data can support outbreak surveillance, antimicrobial-resistance monitoring or research, it must be validated and checked for problems such as malformed records, poor base quality, abnormal nucleotide composition, ambiguous bases, inconsistent read lengths and excessive duplication.
When these problems are not detected early, unreliable data can move into downstream pipelines, consuming limited computing resources and weakening confidence in the final results. Quality control is therefore not an optional extra; it is part of the foundation required for consistent and reliable sequencing data.
The challenge is not that quality-control software does not exist. Mature tools are already available. The unresolved question is whether QC can be made easier to deploy, interpret and incorporate into routine work in laboratories operating with limited staff, computing resources or connectivity.
Africa’s genomics story is one of significant progress. Sequencing equipment, laboratory networks and training programmes have expanded across the continent. However, the workforce and analytical infrastructure required to sustain that progress have not grown at the same pace.
A 2025 analysis estimated an immediate need across African public-health genomics facilities for at least:
The same pattern appears beyond Africa. A 2026 survey of 120 institutions in 52 countries found that sequencing capacity is expanding globally, but substantial operational inequalities remain. Laboratories reported constraints involving data storage, analysis capacity, computing infrastructure and sustainable financing. Some lower-resource laboratories relied on shared or underpowered computers, external partners and internet-dependent workflows, limiting their ability to analyse data locally and on time.
WHO has also emphasised that expanding sequencing requires a parallel increase in the capacity to store, process, interpret and share genomic data. Its global strategy aims for all 194 Member States to have timely access to pathogen sequencing by 2032—but access must extend across the complete workflow, not stop at the sequencing instrument.
The emerging gap is clear: more laboratories can generate genomic data, but not every laboratory has a practical, sustainable way to assess that data before using it.
Kmeggie+ is an early-stage genomics quality-control platform designed around the operating realities of African and other lower-resource laboratories.
It focuses on the critical first checkpoint after sequencing: validating raw FASTQ files, identifying potential quality problems and presenting the findings clearly before the data enters more complex downstream analysis.
The current Kmeggie+ prototype:
Kmeggie+ is developing a production command-line workflow and formal performance benchmarks. Pipeline orchestration, configurable pass/warn/fail thresholds, standardised institutional reporting, multi-laboratory dashboards and more advanced analysis remain roadmap capabilities—not current product claims.
Kmeggie+ was created to bridge a specific gap: the space between generating a sequencing file and having clear evidence that it is ready for the next stage of analysis.
We believe laboratories should be able to perform essential quality checks close to where their data are generated, without depending on permanent cloud access or scarce specialist availability for every routine validation task.
Kmeggie+ is not intended to replace bioinformaticians, established QC tools or downstream analytical pipelines. It is being built to complement them—reducing repetitive validation work, making QC results easier to understand and helping laboratories establish more consistent, locally managed workflows.
The long-term goal is to help ensure that investments in sequencing instruments, laboratory networks and scientific training translate into dependable genomic evidence and stronger local ownership of public-health data.
Sequencing capacity is growing. Confidence in the data must grow with it.
Kmeggie+ — Sequencing, simplified.
BUILD WITH US